Sunday, May 05, 2024
name of Prensa Latina
Bandera inglesa
English Edition
Search
Close this search box.
name of Prensa Latina

NEWS

clinical

Havana, Jul 31 (Prensa Latina) The Soberana Centro clinical trial that began on July 26 in the province of Cienfuegos is proceeding according to the corresponding protocols, national authorities reported.
Havana, Jun 14 (Prensa Latina) Cuba has begun on Monday phases I/II of the clinical trials of its Soberana 02 and Soberana Plus Covid-19 vaccines on Children and teenagers, with two doses of the former and one of the later.
Havana, Jun 11 (Prensa Latina) Cuban President Miguel Diaz-Canel on Friday described as transcendental the approval by health authorities of the start of the anti-Covid-19 clinical trials in pediatric people, using the vaccine candidates from the Caribbean island.
Havana, May 20 (Prensa Latina) With the Covid-19 pandemic, the term clinical trial is becoming more popular among the Cuban population, a research methodology used for the first time in 1747 and celebrates its international day this Thursday.
Havana, Apr 26 (Prensa Latina) Abdala, Cuba's vaccine candidate against Covid-19, will conclude this week the administration of the third dose to all volunteers as part of the 3rd phase of clinical trials, it was announced on Monday.
Santiago de Cuba, Apr 20 (Prensa Latina) With the information to the volunteers who received the placebos and the inoculation of the first dose of the vaccine candidate Abdala, this clinical trial is currently taking place in this city.
Santiago de Cuba, Apr 13 (Prensa Latina) A team of over 500 researchers are holding today in eastern Cuba the clinical trial of the Abdala vaccine candidate, informed Dr. Francisco Hernandez from the Center for Genetic Engineering and Biotechnology (CIGB).
Havana, Apr 6 (Prensa Latina) Covid-19 symptoms and fever as a frequent clinical expression were some of the most relevant features found in Cuban patients with this disease, a study conducted in Havana states on Tuesday.
Havana, Apr 5 (Prensa Latina) Cuba's anti-Covid-19 vaccine candidates Soberana 02 and Abdala (CIGB-66) enter on Monday in the administration of the second dose in Phase III of clinical trials, each day closer to demonstrating their response capacity to fight SARS-Cov-2.